key: cord-0829199-0at1uvsi
authors: Hudhud, Dania; Caldera, Freddy; Cross, Raymond K
title: Addressing COVID-19 Vaccine Hesitancy in Patients with IBD
date: 2021-09-24
journal: Inflamm Bowel Dis
DOI: 10.1093/ibd/izab241
sha: ceba0950b2ce8929022f86c0801d567b3373d703
doc_id: 829199
cord_uid: 0at1uvsi

It is recommended that all patients with IBD undergo vaccination against COVID-19. In this commentary, we encourage IBD providers to serve as vaccine advocates and suggest implementing different methods for battling misinformation, paying careful attention to minority population.

and misconceptions circulating on social media. It is crucial to identify social and systemic immunization barriers, in addition to properly educating patients on vaccine safety to improve the vaccination rate among the IBD population.

Inflammatory bowel disease providers may not be able to overcome all barriers to vaccination but should adopt an active role in battling misinformation, dismissing myths, addressing hesitancies, and understanding the reason for the reluctance to receive vaccination among their patients. Provider communication and continuous reinforcement should be incorporated in routine clinic visits and tailored to patient's needs and concerns. Using available resources including pharmacists, nursing staff, and electronic messaging systems may further assist in identifying concerns and lead to a more productive conversation. Therefore, strategies for effective vaccine counseling include acknowledging concerns, discussing the benefits of immunization and risks of infection, and providing a strong recommendations to receive a COVID-19 vaccine to all patients with IBD. 10 Disparities in health and health care remain a major challenge in the care of minority populations and are associated with worse clinical outcomes. In patients with IBD, racial disparities already exist in many aspects of their care. Non-White patients are at a higher risk for care fragmentation which results in higher health care costs following an IBD hospitalization. 11 Additionally, Black patients receive a disproportionate amount of hospital-based care compared with ambulatory care, resulting in missed opportunities for preventive health care interventions. 12, 13 The emergence of the COVID-19 pandemic has further shed light on those health care disparities, with a lag of vaccination interest in minority patients. Since the EUA for the COVID-19 vaccines, significant gaps in vaccine uptake have been seen in ethnic minorities. 14,15 A recent CDC survey showed that vaccination nonintent is highest amongst minority populations including younger adults, Black persons, adults with lower education and lower income, and those without insurance. 16 This highlights the importance of targeting the minority population, displaying cultural sensitivity, and taking extra measures to ensure equity in vaccine uptake and distributionultimately preventing the spread of COVID-19. 10 

To educate our patients with IBD and identify their concerns about vaccinations, we developed an educational COVID-19 vaccine video. Our goal was to determine if providing an educational intervention would result in increased willingness to receive a COVID-19 vaccine. The video was performed by a gastroenterologist who discussed the rationale for COVID-19 vaccines, as well as the efficacy and the safety of the vaccine specifically in relation to patients with IBD. The video was followed by a survey that contained demographic questions, vaccination intent, and concerns about vaccination. This was sent in the form of an electronic health portal message. The message was sent to unvaccinated patients in our practice after the vaccine was widely available to all adults in the state. A total of 45 patients responded. After watching the video, 43 of the 45 respondents answered "absolutely certain" or "very likely" to receive the COVID-19 vaccine. Additionally, 35 of the 45 patients responded that the video information was "very helpful" or "somewhat helpful" in making an informed decision regarding COVID-19 vaccination. Based on our results, we suggest that providing tailored education content in the form of a video may be a valuable tool in decreasing vaccine hesitancy in patients with IBD and potentially in those with other chronic conditions. In addition to increasing vaccination knowledge and awareness, other proposed methods include improving convenience and access to vaccination, targeting specific populations, and engaging influential persons to promote vaccination. 17 We strongly recommend that IBD providers assume the role of COVID-19 vaccine advocates to patients, provide appropriate counseling, and utilize available resources to ensure equitable vaccine distribution amongst their patients. Additionally, the implementation of dedicated services may improve adherence to vaccination programs for patients with IBD and help protect them from a vaccine-preventable disease. Careful attention needs to be paid to vaccination nonintent in minority populations to decrease health and health care disparities within the community. Further studies are needed to identify hesitancy towards vaccination and its effect in the IBD population and search for predictive markers for vaccination success.

Dr. Cross has participated in advisory boards for Janssen and Pfizer. Dr. Caldera has received research support from Takeda Pharmaceuticals and Sanofi; he has been a consultant for Takeda, Arena Pharmaceuticals, GSK, and Celgene.

Impact of left ventricular function on clinical outcomes of functional mitral regurgitation patients undergoing transcatheter mitral valve repair

Adverse events after SARS-CoV-2 mRNA vaccination among patients with inflammatory bowel disease

Immunogenicity of high dose influenza vaccine for patients with inflammatory bowel disease on anti-TNF monotherapy: a randomized clinical trial

Humoral immune response to messenger RNA COVID-19 vaccines among patients with inflammatory bowel disease

Elevated adherence to vaccination against SARS-CoV-2 among patients with inflammatory bowel disease

Acceptance of SARS-CoV-2 vaccination among a cohort of IBD patients from Southern Italy: a cross-sectional survey

Inflammatory bowel disease and COVID-19 vaccination: a patients' survey

SARS-CoV-2 vaccination in patients with inflammatory bowel disease-fear and desire

COVID-19 vaccination intent and perceptions among patients with inflammatory bowel diseases

Ensuring high and equitable COVID-19 vaccine uptake among patients with IBD

Fragmented care is prevalent among inflammatory bowel disease readmissions and is associated with worse outcomes

Assessing national trends and disparities in ambulatory, emergency department, and inpatient visits for inflammatory bowel disease in the United States

Immunization rates and vaccine beliefs among patients with inflammatory bowel disease: an opportunity for improvement

COVID-19 vaccination coverage among adults -United States

Disparities in COVID-19 vaccination coverage between urban and rural counties -United States

COVID-19 vaccination intent, perceptions, and reasons for not vaccinating among groups prioritized for early vaccination -United States

SAGE Working Group on Vaccine Hesitancy. Strategies for addressing vaccine hesitancy -a systematic review